Year: 2023
Type: article
Abstract: In this Viewpoint we discuss how experimental medicine applied in the setting of clinical trials can address unmet need in the prototypic autoimmune disease systemic lupus erythematosus (SLE) to improve outcomes for patients.
DOI: 10.1084/jem.20230559
Authors: Michael R. Ehrenstein, Muhammad Shipa
Institution: University College London
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Award: G3925664166
OpenAlex ID: W4366991771